1. Home
  2. USA vs DYN Comparison

USA vs DYN Comparison

Compare USA & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USA
  • DYN
  • Stock Information
  • Founded
  • USA 1986
  • DYN 1984
  • Country
  • USA United States
  • DYN United States
  • Employees
  • USA N/A
  • DYN N/A
  • Industry
  • USA Finance Companies
  • DYN Medicinal Chemicals and Botanical Products
  • Sector
  • USA Finance
  • DYN Health Care
  • Exchange
  • USA Nasdaq
  • DYN Nasdaq
  • Market Cap
  • USA 1.9B
  • DYN 1.9B
  • IPO Year
  • USA N/A
  • DYN 2020
  • Fundamental
  • Price
  • USA $6.42
  • DYN $14.51
  • Analyst Decision
  • USA
  • DYN Strong Buy
  • Analyst Count
  • USA 0
  • DYN 14
  • Target Price
  • USA N/A
  • DYN $34.93
  • AVG Volume (30 Days)
  • USA 880.5K
  • DYN 2.5M
  • Earning Date
  • USA 01-01-0001
  • DYN 11-11-2025
  • Dividend Yield
  • USA 9.66%
  • DYN N/A
  • EPS Growth
  • USA N/A
  • DYN N/A
  • EPS
  • USA N/A
  • DYN N/A
  • Revenue
  • USA N/A
  • DYN N/A
  • Revenue This Year
  • USA N/A
  • DYN N/A
  • Revenue Next Year
  • USA N/A
  • DYN N/A
  • P/E Ratio
  • USA N/A
  • DYN N/A
  • Revenue Growth
  • USA N/A
  • DYN N/A
  • 52 Week Low
  • USA $5.62
  • DYN $6.36
  • 52 Week High
  • USA $7.09
  • DYN $35.90
  • Technical
  • Relative Strength Index (RSI)
  • USA 41.40
  • DYN 59.18
  • Support Level
  • USA $6.31
  • DYN $12.43
  • Resistance Level
  • USA $6.56
  • DYN $14.27
  • Average True Range (ATR)
  • USA 0.06
  • DYN 0.73
  • MACD
  • USA 0.00
  • DYN 0.04
  • Stochastic Oscillator
  • USA 36.04
  • DYN 85.53

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: